Alcon Purchases Moore Microprocessor Patent™ Portfolio License

CUPERTINO, Calif. – September 10, 2009 – Alliacense announced today that Alcon Inc. has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Alcon, Inc. develops, manufactures and markets surgical, pharmaceutical, and consumer vision care products.

The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world’s leading manufacturers of end-user products from around the globe to become MMP Portfolio Licensees.  Over 60 global companies from the US, Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio technologies.

The MMP Portfolio patents, filed by The TPL Group in the 1980s, cover techniques that enable higher performance and lower cost designs, and are fundamental to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players to communications infrastructure, medical equipment — and automobiles which today have dozens of microprocessor-based key features and benefits.

About the MMP Portfolio

The Moore Microprocessor Patent Portfolio contains intellectual property that is jointly owned by the privately-held TPL Group and publicly-held Patriot Scientific Corporation (OTCBB: PTSC). The MMP Portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is widely recognized that the MMP Portfolio protects fundamental technology used in microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. Manufacturers of microprocessor-based products can learn more about how to participate in the MMP Portfolio Licensing Program by contacting: mmp-licensing@alliacense.com.

About Alliacense

Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL’s IP portfolios. Founded in 1988, The TPL Group has emerged as a coalition of high technology enterprises involved in the development, management and commercialization of proprietary product technologies as well as the design, manufacture and sales of proprietary products based on those technologies and corresponding IP assets. For more information, visit www.alliacense.com.

 #    #    # 

Alliacense and Moore Microprocessor Patent (MMP) are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.

Posted in IP News, Medical Equipment, MMP™ Portfolio Tagged with: